Armata Pharmaceuticals, Inc.
ARMP · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $66,898 | $116,886 | $42,525 | $132,090 |
| - Cash | $9,291 | $13,523 | $14,852 | $10,288 |
| + Debt | $126,515 | $120,371 | $48,815 | $37,989 |
| Enterprise Value | $184,122 | $223,734 | $76,488 | $159,791 |
| Revenue | $5,174 | $4,529 | $5,508 | $4,474 |
| % Growth | 14.2% | -17.8% | 23.1% | – |
| Gross Profit | -$29,252 | $3,557 | -$29,509 | -$15,541 |
| % Margin | -565.4% | 78.5% | -535.7% | -347.4% |
| EBITDA | -$41,111 | -$65,447 | -$36,054 | -$21,922 |
| % Margin | -794.6% | -1,445.1% | -654.6% | -490% |
| Net Income | -$18,916 | -$69,045 | -$36,917 | -$23,155 |
| % Margin | -365.6% | -1,524.5% | -670.2% | -517.5% |
| EPS Diluted | -0.523 | -1.91 | -1.08 | -0.96 |
| % Growth | 72.6% | -76.9% | -12.5% | – |
| Operating Cash Flow | -$37,551 | -$47,423 | -$32,481 | -$23,575 |
| Capital Expenditures | -$1,879 | -$8,144 | -$2,211 | -$1,304 |
| Free Cash Flow | -$39,430 | -$55,567 | -$34,692 | -$24,879 |